Evidence map›Paper›PMID 32065743›Full record

ArticleACS chemical biology2020

Chemoenzymatic Semisynthesis of Phosphorylated α-Synuclein Enables Identification of a Bidirectional Effect on Fibril Formation.

Buyan Pan, Elizabeth Rhoades, E James Petersson

Abstract read
In one paragraph

Article in ACS chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Current Understanding of Protein Aggregation in Neurodegenerative Diseases.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Synthesis of Peptides and Proteins with Site-Specific Glutamate Arginylation.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  16. Monitoring α-synuclein aggregation.Neurobiology of disease · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Buyan PanDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Elizabeth RhoadesDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
E James PeterssonDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0003-3854-9210

Funding

Role of arginylation in prevention of alpha synuclein-driven neurodegenerationR01NS102435 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI KASHINA, ANNA S · 2019 to 2023
$2.6M
Studying Aggregation in Neurodegenerative Disease Using Synthetic ProteinsR01NS103873 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Ernest James Petersson · 2019 to 2026
$2.1M
Studying Aggregation in Neurodegenerative Disease using Synthetic ProteinsRF1NS103873 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI PETERSSON, ERNEST JAMES · 2023 to 2023
$1.8M
Self-association and membrane-binding of alpha-synucleinR01NS079955 · NINDS · YALE UNIVERSITY · PI RHOADES, ELIZABETH · 2013 to 2017
$1.7M
Semi-synthetic a-Synuclein for Tracking Aggregation and Cell-to-Cell TransmissionR01NS081033 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI PETERSSON, ERNEST JAMES · 2012 to 2015
$1.3M
Semi-synthetic a-Synuclein for Tracking Aggregation and Cell-to-Cell TransmissionR56NS081033 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI PETERSSON, ERNEST JAMES · 2017 to 2017
$357k
NINDS NIH HHS R01 NS079955NINDS NIH HHS R01 NS081033NINDS NIH HHS R01 NS102435NINDS NIH HHS R01 NS103873NINDS NIH HHS R56 NS081033NINDS NIH HHS RF1 NS103873
6 · The paper itself

Abstract

Post-translational modifications (PTMs) impact the pathological aggregation of α-synuclein (αS), a hallmark of Parkinson's disease (PD). Here, we synthesize αS phosphorylated at tyrosine 39 (pY

Indexed as

alpha-SynucleinAmino Acid SequenceAmyloidFluorescence Resonance Energy TransferFluorescent DyesIntercalating AgentsModels, MolecularMutant ProteinsMutationParkinson DiseasePeptide FragmentsPhosphorylationProtein ConformationProtein Processing, Post-TranslationalSingle Molecule ImagingSolid-Phase Synthesis Techniquesalpha-SynucleinAmyloidFluorescent DyesIntercalating AgentsMutant ProteinsPeptide Fragments

Identifiers

PMID32065743
PMCPMC7724256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.